2022
DOI: 10.1152/ajprenal.00277.2021
|View full text |Cite
|
Sign up to set email alerts
|

Cystinosin-deficient rats recapitulate the phenotype of nephropathic cystinosis

Abstract: The lysosomal storage disease cystinosis is caused by mutations in CTNS, encoding a cystine transporter, and in its severest form leads to proximal tubule dysfunction followed by kidney failure. Patients receive the drug-based therapy cysteamine from diagnosis. However, despite long-term treatment, cysteamine only slows the progression of end-stage renal disease. Pre-clinical testing in cystinotic rodents is required to evaluate new therapies; however, the current models are sub-optimal. To solve this problem … Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 49 publications
(53 reference statements)
0
1
0
Order By: Relevance
“…To assess and cross-validate the structural and functional impact of these lysosomal changes in human cystinotic RPTECs we generated a CTNS -/- in vitro, HuIm RPTEC cystinosis model (16, 46). We found an association between the knocking out of the CTNS and the downregulation of v-ATPases.…”
Section: Discussionmentioning
confidence: 99%
“…To assess and cross-validate the structural and functional impact of these lysosomal changes in human cystinotic RPTECs we generated a CTNS -/- in vitro, HuIm RPTEC cystinosis model (16, 46). We found an association between the knocking out of the CTNS and the downregulation of v-ATPases.…”
Section: Discussionmentioning
confidence: 99%